Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Acrivon Therapeutics Inc (NASDAQ: ACRV) closed the day trading at $1.16 down -1.69% from the previous closing price of $1.18. In other words, the price has decreased by -$1.69 from its previous closing price. On the day, 0.63 million shares were traded.
Ratios:
For a better understanding of ACRV, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.55 and its Current Ratio is at 10.55. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Ladenburg Thalmann Upgraded its Neutral to Buy on September 16, 2024, while the target price for the stock was maintained at $16.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 30 ’25 when PERCEPTIVE ADVISORS LLC sold 437,881 shares for $1.41 per share. The transaction valued at 617,412 led to the insider holds 3,403,025 shares of the business.
PERCEPTIVE ADVISORS LLC sold 298,886 shares of ACRV for $400,507 on May 01 ’25. The 10% Owner now owns 3,104,139 shares after completing the transaction at $1.34 per share. On Apr 25 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the 10% Owner of the company, sold 1,054,669 shares for $1.95 each. As a result, the insider received 2,056,605 and left with 4,306,189 shares of the company.
Stock Price History:
Over the past 52 weeks, ACRV has reached a high of $10.16, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -61.50%, while the 200-Day Moving Average is calculated to be -81.01%.
Shares Statistics:
A total of 31.23M shares are outstanding, with a floating share count of 21.74M. Insiders hold about 30.67% of the company’s shares, while institutions hold 58.44% stake in the company.
